Alpha 2b IFN, HDEDX, CDDP and lonidamina in advanced breast cancer (ABC). Preliminary data of a randomized phase II study / Iaffaioli, Rv; Santangelo, Michele; .,. - STAMPA. - Proceeding of 33 Annual Meeting of American Society of Clinical Oncology:(1997), pp. 606-606. (Intervento presentato al convegno 33 Annual Meeting of American Society of Clinical Oncology tenutosi a Denver (Co) nel May 17th-20th, 1997).

Alpha 2b IFN, HDEDX, CDDP and lonidamina in advanced breast cancer (ABC). Preliminary data of a randomized phase II study.

SANTANGELO, MICHELE;
1997

1997
Alpha 2b IFN, HDEDX, CDDP and lonidamina in advanced breast cancer (ABC). Preliminary data of a randomized phase II study / Iaffaioli, Rv; Santangelo, Michele; .,. - STAMPA. - Proceeding of 33 Annual Meeting of American Society of Clinical Oncology:(1997), pp. 606-606. (Intervento presentato al convegno 33 Annual Meeting of American Society of Clinical Oncology tenutosi a Denver (Co) nel May 17th-20th, 1997).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/483812
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact